How does procalcitonin-guided decision-making affect the duration of antibiotic therapy in neonates in low- and middle-income countries?

No direct evidence for neonates in low- and middle-income countries on procalcitonin-guided decision-making was identified. While studies support its potential to reduce antibiotic duration in neonatal sepsis, more context-specific research is necessary to address local healthcare challenges.